Roberto Olayo-Alarcon

Roberto Olayo-Alarcon

Auto-generated profile, based on publicly available information

Roberto Olayo-Alarcon

Department of Statistics, Ludwig-Maximilians-Universität München

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
RORoberto Olayo-Alarcon
Roberto Olayo-Alarcon
MAMartin K. Amstalden
Martin K. Amstalden
AZAnnamaria Zannoni
Annamaria Zannoni
MBMedina Bajramovic
Medina Bajramovic
CSCynthia M. Sharma
Cynthia M. Sharma
CMChristian Mueller
Christian Mueller
The rise in antimicrobial resistance poses a worldwide threat, reducing the efficacy of common antibiotics. Determining the antimicrobial activity of new chemical compounds through experimental methods remains time-consuming and costly. While compound-centric deep learning models promise to accelerate this search and prioritization process, current strategies require large amounts of custom training data. Here, we introduce a lightweight computational strategy for antimicrobial discovery that builds on MolE (Molecular representation through redundancy reduced Embedding), a self-supervised deep learning framework that leverages unlabeled chemical structures to learn task-independent molecular representations. By combining MolE representation learning with available, experimentally validated compound-bacteria activity data, we design a general predictive model that enables assessing compounds with respect to their antimicrobial potential. Our model correctly identifies recent growth-inhibitory compounds that are structurally distinct from current antibiotics. Using this approach, we discover de novo, and experimentally confirm, three human-targeted drugs as growth inhibitors of Staphylococcus aureus. This framework offers a viable, cost-effective strategy to accelerate antibiotic discovery.

25 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MFMedina Feldl
Medina Feldl
RORoberto Olayo-Alarcon
Roberto Olayo-Alarcon
MAMartin K. Amstalden
Martin K. Amstalden
AZAnnamaria Zannoni
Annamaria Zannoni
SPStefanie Peschel
Stefanie Peschel
CMChristian L. Müller
Christian L. Müller
Quantitative analysis of microbial growth curves is essential for understanding how bacterial populations respond to environmental cues. Traditional analysis approaches make parametric assumptions about the functional form of these curves, limiting their usefulness for studying conditions that distort standard growth curves. In addition, modern robotics platforms enable the high-throughput collection of large volumes of growth data, thus requiring strategies that can analyze large-scale growth data in a flexible and efficient manner. Here, we introduce DGrowthR , a statistical R framework and standalone app with a no-code interface for the integrative analysis of large growth experiments. DGrowthR comprises methods for data pre-processing and standardization, exploratory functional data analysis, and non-parametric modeling of growth curves using Gaussian Process regression. Importantly, DGrowthR includes a rigorous statistical testing framework for differential growth (DG) analysis. To illustrate the range of application scenarios of DGrowthR , we analyzed three large-scale bacterial growth datasets targeting distinct scientific inquiries. On an in-house dataset comprising more than 20, 000 growth curves of two pathogens that were subjected to chemical perturbations, DGrowthR enabled the discovery of compounds with significant growth inhibitory effects as well as compounds that induce non-canonical growth dynamics. On two publicly available perturbation datasets (> 100, 000 growth curves), DG analysis recovered reported adjuvants and antagonists of antibiotic activity, as well as bacterial genetic factors that determine susceptibility to specific antibiotic treatments. We anticipate DGrowthR to streamline the analysis of high-volume growth experiments, enabling researchers to make biological discoveries in a standardized and reproducible manner.

27 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JOJohannes Ostner
Johannes Ostner
TKTim Kirk
Tim Kirk
RORoberto Olayo-Alarcon
Roberto Olayo-Alarcon
JTJanne Gesine Thöming
Janne Gesine Thöming
ARAdam Z. Rosenthal
Adam Z. Rosenthal
CMChristian Mueller
Christian Mueller
Bacterial single-cell RNA sequencing has the potential to elucidate within-population heterogeneity of prokaryotes, as well as their interaction with host systems. Despite conceptual similarities, the statistical properties of bacterial single-cell datasets are highly dependent on the protocol, making proper processing essential to tap their full potential. We present BacSC, a fully data-driven computational pipeline that processes bacterial single-cell data without requiring manual intervention. BacSC performs data-adaptive quality control and variance stabilization, selects suitable parameters for dimension reduction, neighborhood embedding, and clustering, and provides false discovery rate control in differential gene expression testing. We validated BacSC on a broad selection of bacterial single-cell datasets spanning multiple protocols and species. Here, BacSC detected subpopulations in Klebsiella pneumoniae , found matching structures of Pseudomonas aeruginosa under regular and low-iron conditions, and better represented subpopulation dynamics of Bacillus subtilis . BacSC thus simplifies statistical processing of bacterial single-cell data and reduces the danger of incorrect processing.

11 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
RORoberto Olayo-Alarcon
Roberto Olayo-Alarcon
MAMartin K. Amstalden
Martin K. Amstalden
AZAnnamaria Zannoni
Annamaria Zannoni
MBMedina Bajramovic
Medina Bajramovic
CSCynthia M. Sharma
Cynthia M. Sharma
CMChristian Mueller
Christian Mueller
The rise in antimicrobial resistance poses a worldwide threat, reducing the efficacy of common antibiotics. Determining the antimicrobial activity of new chemical compounds through experimental methods is still a time-consuming and costly endeavor. Compound-centric deep learning models hold the promise to speed up this search and prioritization process. Here, we introduce a lightweight computational strategy for antimicrobial discovery that builds on MolE ( Mol ecular representation through redundancy reduced E mbedding), a deep learning framework that leverages unlabeled chemical structures to learn task-independent molecular representations. By combining MolE representation learning with experimentally validated compound-bacteria activity data, we design a general predictive model that enables assessing compounds with respect to their antimicrobial potential. The model correctly identified recent growth-inhibitory compounds that are structurally distinct from current antibiotics and discovered de novo three human-targeted drugs as Staphylococcus aureus growth inhibitors which we experimentally confirmed. Our framework offers a viable cost-effective strategy to accelerate antibiotics discovery.

1 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MAMartin K. Amstalden
Martin K. Amstalden
RORoberto Olayo-Alarcón
Roberto Olayo-Alarcón
SBSusanne Brenzinger
Susanne Brenzinger
LDLorine Debande
Lorine Debande
AZAnnamaria Zannoni
Annamaria Zannoni
ABAna Rita Brochado
Ana Rita Brochado
Human-targeted drugs are increasingly recognized to affect bacterial physiology, yet their impact beyond growth inhibition, and the underlying molecular mechanisms, remain poorly understood. Here, we systematically mapped how chemically diverse host-associated compounds influence virulence and intrinsic antibiotic resistance in Salmonella enterica serovar Typhimurium. Using a high-throughput reporter approach, we quantified transcriptional response of 26 key stress promoters in Salmonella against 2,415 compounds, including FDA-approved drugs, food-derived molecules, and human metabolites. We found that non-antibiotic compounds induce transcriptional responses distinct from those elicited by antibiotics, uncovering a regulatory shift from general stress responses to compound-specific regulation driven by ligand-responsive MarR- and TetR-family regulators. In particular, more than 200 non-antibiotic drugs modulate virulence or intrinsic resistance pathways through the central regulators SlyA or RamR, respectively. By integrating our large-scale dataset with machine learning, we further defined chemical features associated with ramA transcriptional activation in Salmonella , and predicted ∼200 additional candidate inducers of intrinsic antibiotic resistance in this pathogen. Together, our results uncovered a large and previously unrecognized chemical landscape that reshapes bacterial stress responses through ligand-responsive regulatory mechanisms, with implications for how host-associated compounds influence pathogen virulence and antibiotic resistance. Highlights: Mapping the transcriptional response of key Salmonella stress pathways across a large chemical space shows that antibiotics and non-antibiotic compounds elicit distinct stress responses in Salmonella The activity of the virulence regulator SlyA is modulated by non-antibiotic compounds SlyA-inhibitors increase sensitivity to polymyxin B and decrease Salmonella virulence in cell culture Human-targeted drugs increase intrinsic antibiotic resistance via RamR-RamA in Salmonella Machine learning approach enables large-scale, out-of-sample prediction of human-targeted drugs inducing ramA expression in Salmonella

26 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CBChristoph Binsfeld
Christoph Binsfeld
RARoberto Olayo Alarcon
Roberto Olayo Alarcon
MWMorgane Wartel
Morgane Wartel
MSMara Stadler
Mara Stadler
CMChristian Müller
Christian Müller
ABAna Rita Brochado
Ana Rita Brochado
Transport of small molecules across the bacterial cell envelope is essential to ensure nutrient uptake and protect bacteria from toxic compounds. Due to its decisive role, transport is controlled by complex regulatory networks, knowledge of which – in particular across external cues – remains poorly understood. Here we investigate transcriptional regulation of seven prominent transport genes in Escherichia coli across 94 defined chemical cues, and simultaneously map the contributions of the key regulators MarA, SoxS and Rob to promoter activity. One third of all tested compounds triggered transcriptional changes, the vast majority of which previously unknown. Importantly, we exposed main drivers of transport control in E. coli , e.g. bacteriostatic, but not bactericidal, antibiotics trigger expression of efflux pumps, and that Rob contributes to ∼1/3 of all measured transcriptional changes, thereby emerging as a more prominent transport regulator than previously thought. We showcase the potential of our resource by elucidating the molecular mechanism of antibiotic antagonisms with widely consumed caffeine in E. coli . Altogether, our resource capitalizes on providing a quantitative overview of transport determinants across environments, and brings perspective to long-term prevailing concepts in the field.